Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-11-16
2008-01-01
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S001730, C424S001810, C424S001850, C424S009100
Reexamination Certificate
active
07314609
ABSTRACT:
The present invention provides novel imaging agents for clinical diagnosis of injuries and diseases, in the form of a radionuclide in spatial proximity to a substantially pure stereoisomer of a fatty acid analog. The invention also provides methods for using the novel imaging agents, and kits containing one or more of the novel imaging agents of the invention.
REFERENCES:
patent: 3716631 (1973-02-01), Steggerda et al.
patent: 4323547 (1982-04-01), Knust et al.
patent: 4473544 (1984-09-01), Machulla et al.
patent: 4476106 (1984-10-01), Bardy et al.
patent: 4524059 (1985-06-01), Elmaleh et al.
patent: 4746505 (1988-05-01), Jones et al.
patent: 4764358 (1988-08-01), Knapp, Jr. et al.
patent: 4877599 (1989-10-01), Lees
patent: 5021220 (1991-06-01), Mertens
patent: 5370860 (1994-12-01), Elgavish et al.
patent: 5976496 (1999-11-01), Dean et al.
patent: 7005119 (2006-02-01), Elmalch
patent: 2003/0215386 (2003-11-01), Elmalch
Caveliers et al., “Intra-Individual Comparison of 3(R)-BMIPP and 3(S)-BMIPP Isomers in Humans”, Oct. 1998, pp. 1672-1675, The Journal of Nuclear Medicine, vol. 39, No. 10.
Chang et al; “The Effect of Methyl Palmoxirate on Incorporation of [U14C] Palmitate Into Rat Brain”, Neurochemical Research 19(9): 1217-1223, (1994).
Communal et al.; Can. J. Physiol. Pharmacol., vol. 72:1120-1126, (Oct. 1994).
Cravatt et al., “Chemical Characterization Of A Family Of Brain Lipids That Induce Sleep”, Science, vol. 268: 1506-1509 (1995).
De Geeter et al. “Relationship between blood flow and fatty acid metabolism in subacute myocardial infartion: a stucy by means of Tc-Sestamibi and I-.beta.-methyl-iodo-phenyl pentadecanoic acid,” Eur. J. Nucl. Med 21: 283-291, 1994.
Elmaleh et al., “Corporation of11C and14C-Labeled Fatty Acids And Their β-Methyl Analogs”, Int. J. Nucl. Med. Biol. vol. 10, No. 4: 181-187 (1983).
Elmaleh et al., “Myocardial Extraction of 1-[11C] Betamethylheptadecanoic Acid”, The Journal of Nuclear Medicine, vol. 35, No. 3: 496-503 (1994).
Franken et al., A. “Abnormal Free Fatty Acid Uptake in Subacute Myocardial Infarction After Coronary Thrombolysis: Correlation with Wall Motion and Inotropic Reserve,”.J. Nucl. Med. 35: 1758-1765, 1994.
Goodman et al., “Synthesis and Evaluation of Radioiodinated Terminal p-Iodophenyl-Substituted .alpha.- and β-Methyl-Branched Fatty Acids,” J. Med. Chem., 27:390-397 (1984).
Lin et al., “Effects of Configuration on the Myocardial Uptake of Radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in Rats,” J Nucl. Med. 38:1434-1440, 1997.
Livni et al., “Beta-methyl[1-11C] heptadecanoic Acid: A New Myocardial Metabolic Tracer For Positron Emission Tomography”, The Journal of Nuclear Medicine, vol. 23, No. 2: 169-175 (1982).
Fischman et al., “Myocardial Fatty Acid Imaging: Rationale, Comparison of11C- and123I-Labeled Fatty Acids, and Potential Clinical Utility”, American Journal of Cardiac Imaging, vol. 3, No. 4: 288-296 (1989).
Gatley et al., “On the rate-limiting step in myocardial clearance of label from 16-iodohexadecanoic acid,” J. Nucl. Med. 24: P12, 1983 (abstr.).
Goodman et al., “New Myocardial Imaging Agents: Synthesis of 15-(p-Iodophenyl)-3(R,S)- methylpentadecanoic Acid by Decomposition of a 3,3-(1,5-Pentanediyl) triazene Precursor”, The Journal of Organic Chemistry, vol. 49, No. 13: 2322-2325 (1984).
Jones Jr., et al., “Synthesis and Biodistributionof a New99mTechnetium Fatty Acid”, Nuclear Medical Biology, vol. 21, No. 1: 117-123 (1994).
Kairento et al., “Comparative Evaluation of [123I]I4-p-Iodophenyl-Beta-Methyltetradecanoic Acid and Thallium-201 in the Detection of Infarcted Areas in the Dog Heart Using SPECT”, Nuclear Medical Biology, vol. 15, No. 3:333-338 (1988).
Knapp, Jr. “Myocardial Metabolism of Radioiodinated BMIPP”, The Journal of Nuclear Medicine, vol. 36, No. 6: 1051-1054 (1995).
Kropp et al., “Evaluation of ischemia and myocardial viability in patients with coronary artery disease (CAD) with iodine-123 labeled 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP),” BMIPP. Ann Nucl Med 7: 93-100, 1993.
Lin et al., “Effects of Configuration on the Myocardial Uptake of Radioiodinated 3(R)-BMIPP and 3(S)-BMIPP in Rats”, Sep. 1997, pp. 1434-1441, The Journal of Nuclear Medicine, vol. 38, No. 9.
Machulla et al, “Comparative Evaluation of Fatty Acids Labeled with C-11, C1-34m, Br-77 and I-123 for Metabolic Studies of the Myocardium: Concise Communication,” J. Nucl. Med. 19:298-302, 1978.
Mertens et al.; European Journal Of Nuclear Medicine, vol. 13(3): 159-160, (1987).
Miller et al., “Fatty Acid Analogue Accumulation: A Marker of Myocyte Viability in Ischemic-Reperfused Myocardium” Circulation Research, vol. 63, No. 4: 681-692 (1988).
Most et al., “Free Fatty Acid Metabolism of the Human Heart at Rest,” J. Clin. Invest. 48:1177-1188, 1969.
Nakai et al., “Serial Course of Left Ventricular Function, Perfusion and Fatty Acid Uptake in the Cardiomyopathic Hamster”, The Journal of Nuclear Medicine, vol. 34, No. 8: 1309-1315 (1993).
Nariai et al.; “In Vivo Incorporation of[9,103H]- Palmitate Into a Rat Metastatic Brain-Tumor Model”, J. Neurosurg. 74: 643-649, (1991).
Naruse et al.; Kakuigaku, 29(1): 77-84 (1992).
Neely et al., Myocardial Utilization of Carbohydrates and Lipids, Progr. Cardiovasc. Res. 15:289-329, 1972.
Neely et al., “Relationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle,” Ann. Rev. Physiol. 36: 413-459, 1974.
Okada et al., “Myocardial Kinetics of1231-Labeled-16-Hexadecanoic Acid”, European Journal of Nuclear Medicine, vol. 8: 211-217 (1983).
Opie, “Metabolism of the heart in health and disease,” Am. Heart J. 76: 685-698, 1968.
Poe, Robinson GD Jr., MacDonald NS, “Myocardial Extraction of Labeled Long-Chain Fatty Acid Analogs,” Proc. Soc. Exp. Biol. Med 148:215-218, 1975.
Takahashi et al.; “Synthesis of 1-11C-Labeled Fatty Acid From [11C]HCN”, Appl. Radiat. Isot. 41(7); 649-654, (1990).
Saito et al., “Differentiation of Regional Perfusion And Fatty Acid Uptake In Zones Of Myocardial Injury”, Nuclear Medicine Communications, vol. 12: 663-675 (1991).
Schon, et al, “C-11 palmitic acid for the noninvasive evaluation of regional fatty acid metabolism with positron-computed tomography,” Am. Heart J. 103: 532-561, 1982.
Schon et al, “Measurement of Myocardial Fatty Acid Metabolism: Kinetics of Iodine-123 Heptadecanoic Acid in Normal Dog hearts,” J. Nucl. Med. 27: 1449-1455, 1986.
Solomons, “Fatty Acids and Glyceryl Trialkanoates”, Organic Chemistry, Fourth Edition, pp. 1039-1043 (1988).
Takeishi et al.; Annals of Nuclear Medicine, 9(3): 125-130, (Aug. 1995).
Wakasugi et al., “Myocardial Utilization And Left Ventricular Function In Adrianmycin Caryomyopathy”, The Journal of Nuclear Medicine, vol. 34, No. 9: 1529-1535 (1993).
Yamamoto et al., “Dual Tracer Autoradiographic Study of β-Methyl-(114C) Heptadecanoic Acid and 15-p-(131I)-Iodophenyl-.beta.-Methylpentadecanoic Acid In Normaotensive and Hypertensive Rats”, The Journal of Nuclear Medicine, vol. 27, No. 7: 1178-1183 (1986).
Yonekura et al., “Regional Myocardial Substrate Uptake in Hypertensive Rats: A Quantitative Autoradiographic Measurement”, Science, vol. 227: 1494-1496 (1985).
Zierler, “Fatty Acids as Substrates for Heart and Skeletal Muscle,” Circ. Res. 38: 459-463, 1976.
Foley & Lardner LLP
Jones Dameron L.
Lomprey Jeffrey R.
Molecular Insight Pharmaceuticals, Inc.
Villacorta Gilberto M.
LandOfFree
Stereoisomers of fatty acid analogs for diagnostic imaging does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stereoisomers of fatty acid analogs for diagnostic imaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stereoisomers of fatty acid analogs for diagnostic imaging will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3962693